Novo Nordisk's Wegovy weight-loss drug approved in China

Novo Nordisk's (NOVOb.CO) hugely popular weight-loss drug Wegovy has been approved in China, it said on Tuesday, the world's second-largest economy and the country estimated to hold the highest number of overweight or obese people.